Global Cord Blood Co. (NYSE:CO – Get Free Report)’s stock price was down 4.9% during trading on Wednesday . The company traded as low as $0.9510 and last traded at $0.9510. 50,070 shares traded hands during mid-day trading, a decline of 77% from the average daily volume of 216,519 shares. The stock had previously closed at $1.00.
Global Cord Blood Price Performance
The company has a 50-day simple moving average of $0.95 and a 200-day simple moving average of $0.96. The firm has a market cap of $115.60 million, a PE ratio of 1.49 and a beta of 0.16.
About Global Cord Blood
Global Cord Blood Corporation (NYSE: CO) is a leading operator of umbilical cord blood banking services in the People’s Republic of China. The company provides critical stem cell preservation and related services through its network of cord blood banks and medical partners. Its core activities encompass the collection, processing, testing, and long-term storage of cord blood units, which are preserved for potential therapeutic use in the treatment of hematological and genetic disorders.
In addition to cord blood banking, Global Cord Blood offers supplemental clinical services such as viability testing, stem cell expansion research, and personalized consultation for expectant parents.
Recommended Stories
- Five stocks we like better than Global Cord Blood
- AirJoule Unveils Prime System, Clearing Path to Commercialization
- Copper Stocks Are Getting a Bigger Spotlight as Gold’s Rally Cracks
- Nike Q4 Beat Masks Core Weakness as Analysts Cut Price Targets
- Uber’s Waymo Detour Tests the Stock’s Robotaxi Bull Case
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.
